Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ATOMOXETINE HYDROCHLORIDE
- Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea
- Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
- Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)
- Pharmacological Agents for Chronic Spinal Cord Injury (SCI)
- Quantitative EEG Neurofeedback as an Add-on Therapy For Attention-deficit Hyperactivity Disorder (ADHD)
- Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy
- Atomoxetine and DAW2022 on OSA Severity
- Rescue Pharmacotherapy for OSA
- A Study to Test Different Ways to Measure the Effect of Atomoxetine on Impulsive Behavior in Young Adults With Attention Deficit Hyperactivity Disorder (ADHD)
- Treatment With Cannabis Oil Containing CBD Only or 20:1 CBD:THC vs. Placebo of Persons With ADHD
- Study of Atomoxetine in the Prevention of Vasovagal Syncope
- Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)
- Parallel Arm Trial of AD109 and AD504 In Patients With OSA
- Measuring Atomoxetine and Aroxybutinin In Patients With OSA
- Trial of AD113 and Atomoxetine in OSA Patients With Hypertension
- Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
- Crossover Trial of AD109 in Obstructive Sleep Apnea
- Enhancing the Effects of Adolescent Alcohol Treatment With Atomoxetine
- Crossover Trial of AD036 in Obstructive Sleep Apnea
- Atomoxetine in Patients With Tourette's Syndrome
- Role of Coenzyme Q in ADHD in Children
- Medications for Obstructive Sleep Apnea In Children With Down Syndrome
- A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
- The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic Study
- A Novel Pharmacological Therapy for Obstructive Sleep Apnea
- Orthostatic Intolerance After Bariatric Surgery
- Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
- Atomoxetine for Freezing of Gait in Parkinson's Disease
- Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH
- Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
- The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
- Long-term Effects of Medication for ADHD
- Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)
- Atomoxetine and Oxybutynin in Obstructive Sleep Apnea
- TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease
- Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
- Norepinephrine Transporter Blockade, Autonomic Failure
- Post-stroke Neural Plasticity With Atomoxetine
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)
- Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
- Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
- EAA/Therapy for Treating Children With ADHD
- The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
- Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD
- Effects of Atx and Oros-mph on Executive Functions
- Atomoxetine in Veterans With Comorbid ADHD/PTSD
- Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects
- Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers
- Safety Study to Assess Atomoxetine With MA Abusers and Healthy Controls
- Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia
- A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment
- Changes in Striatal [11C]ORM-13070 Binding Elicited by Changing Levels of Endogenous Noradrenaline
- Progesterone and Atomoxetine for Cocaine Cessation
- Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)
- Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach
- A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
- Unraveling the Nature of Impaired Pain Inhibition in Patients With Chronic Whiplash-associated Disorders
- Clinical Efficacy of Atomoxetine for Methamphetamine Dependence
- Effects of Atomoxetine in Mild Cognitive Impairment
- Cognitive Effects of Atomoxetine in Humans: Genetic Moderators
- Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline
- A Dose Response Effect of Atomoxetine to the Acute Effects of Alcohol
- Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits
- A Gene by Medication Interaction to the Acute Effects of Alcohol
- Cognitive Decline in Non-demented PD
- Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)
- Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
- Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD
- A Bioequivalence (BE) Study in Healthy Subjects
- Interventions for Children With Attention and Reading Disorders
- Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder
- A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate
- Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children
- Therapeutic Drug Monitoring in Child and Adolescent Psychiatry
- Safety Assessment of Atomoxetine With MA IV Administration
- A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder
- Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder
- Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility
- Driving in Adults With Attention-deficit/Hyperactivity Disorder (ADHD) Before and During Treatment With Atomoxetine
- Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD
- A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder
- Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD)
- Atomoxetine, Placebo and Parent Management Training in Autism
- Efficacy and Safety of St. John´s Wort/Valerian Extract Versus Placebo in Children and Adolescents With ADHD
- Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine
- Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)
- Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia
- Efficacy Study of Strattera for Treating Attention Disorders in Traumatic Brain Injury (TBI)
- A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Agonist Replacement Therapy for Cocaine Dependence
- Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE
- Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Safety Study of Atomoxetine and Cerebrovascular Outcomes
- Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation
- Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial
- Effects of Atomoxetine Treatment in Humans
- Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women
- Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia
- Atomoxetine Effects in Humans
- Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD
- Treatment of Orthostatic Hypotension
- The Reinforcing Mechanisms of Smoking in Adult ADHD
- Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
- The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents
- Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.
- ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD
- The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
- Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Treatment Compliance in Children and Adolescents on ADHD Medication
- Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)
- A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Atomoxetine Pilot Study in Preschool Children With ADHD
- Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes
- Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism
- Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
- Evaluation of Continuous Symptom Treatment of ADHD
- Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD
- Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD
- Combination Therapy in Patients With Depression
- A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD
- Safety Study in Outpatient Japanese Children With ADHD
- Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy
- Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD
- Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine
- A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine
- A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents
- A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Effects of Atomoxetine on Cognitive Function in Schizophrenia
- Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
- Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
- Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany
- Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder
- Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
- Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder
- Atomoxetine and Huntington's Disease
- Atomoxetine Treatment for ADHD and Marijuana Dependence
- Atomoxetine in the Treatment of Binge Eating Disorder
- Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease
- Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL
- Treatment of Executive Dysfunction in Parkinson's Disease
- Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1
- Treatment of Orthostatic Intolerance
- Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder
- Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects
- Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children
- Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents
- Treatment of Orthostatic Hypotension in Autonomic Failure
- A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia
- Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
- Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
- Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.
- Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia
- An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).
- Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)
- Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)
- Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder
- An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder
- Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD
- Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents
- Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes
- Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents
- An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder
- Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)
- Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
- Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD
- Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD
- Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
- Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse
- A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder
- Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder
- A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)
- Long-Term, Open Label Atomoxetine Study
- Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
- Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy
- Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)
- Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar
- Atomoxetine for the Treatment of Cannabis Dependence
- Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia
- Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder
- A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia
- Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD
Clinical trials list
click for details